Announcements Trials
Browse Landscape

Phase

Phase 1 12Phase NA 1Phase 4 1Phase 3 1

Status

Unknown 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other solid neoplasm 1

Conditions

Breast Neoplasms 10Lung Neoplasms 3Carcinoma, Non-Small-Cell Lung 3Thoracic Neoplasms 1Stomach Neoplasms 1Squamous Cell Carcinoma of Head and Neck 1Solid Tumors 1Patient Acceptance of Health Care 1Parkinson Disease 4, Autosomal Dominant Lewy Body 1Ovarian Neoplasms 1Neuroendocrine Tumors 1Neoplasms 1Lung Diseases 1Esophageal Squamous Cell Carcinoma 1Esophageal Neoplasms 1Carcinoma, Ovarian Epithelial 1Carcinoma, Large Cell 1Cancer Therapy-related Cardiovascular Toxicity 1Breast Neoplasm Female 1

Interventions

ribociclib 1encorafenib 1binimetinib 1Paclitaxel 1Cetuximab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 4 × Solid Tumors × Paclitaxel × Clear all
NCT01994031 2014-08-27

Dose Escalation and Pharmacokinetic Study of Paclitaxel Liposome Injection in Treating Patients With Advanced Solid Tumor After Failure From Conventional Treatments

Nanjing Luye Sike Pharmaceutical Co., Ltd.

Phase 4 Unknown
36 enrolled
Other solid neoplasm

Solid Tumors

Data powered by HemOnc (CC BY 4.0) Colophon âš¡